FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation

(MedPage Today) -- The FDA expanded the indication for dextromethorphan hydrobromide and bupropion hydrochloride (Auvelity) extended-release tablets to treat agitation associated with Alzheimer's disease dementia, the agency announced Thursday...
Source
MedPage Today
Opens original article in a new tab



